Journal of International Oncology
Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer
Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali
Journal of International Oncology . 2022, (5): 276 -281 .  DOI: 10.3760/cma.j.cn371439-20220111-00051